Passage BIO, Inc.·4

May 31, 4:33 PM ET

Woiwode Thomas 4

4 · Passage BIO, Inc. · Filed May 31, 2022

Insider Transaction Report

Form 4
Period: 2022-05-26
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-05-26+24,00024,000 total
    Exercise: $1.76Exp: 2032-05-25Common Stock (24,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION